Search research articles
Contact Us
Filters
Showing results (1-10 of 45) with videos related to
Page
of 5
Sort By:
Expert Review of Proteomics
|
December 15, 2010
PI3K-based molecular signatures link high PI3K pathway activity with low ER levels in ER+ breast cancer
Alex Sanchez, Josep Villanueva
Proteomics. Clinical Applications
|
November 25, 2014
Challenges and opportunities for cell line secretomes in cancer proteomics
Olga Méndez, Josep Villanueva
Nature
|
August 6, 2004
OvaCheck: let's not dismiss the concept
Josep Villanueva, Paul Tempst
Annals of Translational Medicine
|
August 15, 2020
Hitting the brakes on autophagy for overcoming acquired resistance in triple negative breast cancer
Chiara Bellio, Josep Villanueva
Methods in Molecular Biology (Clifton, N.J.)
|
October 29, 2022
msmsEDA & msmsTests: Label-Free Differential Expression by Spectral Counts
Josep Gregori, Àlex Sánchez, Josep Villanueva
Biomolecules
|
September 28, 2021
HMGA1, Moonlighting Protein Function, and Cellular Real Estate: Location, Location, Location!
Mireia Pujals, Linda Resar, Josep Villanueva
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 30, 2005
Distilling cancer biomarkers from the serum peptidome: high technology reading of tea leaves or an insight to clinical systems biology?
Richard J Robbins, Josep Villanueva, Paul Tempst
Nature Protocols
|
July 21, 2009
Monitoring peptidase activities in complex proteomes by MALDI-TOF mass spectrometry
Josep Villanueva, Arpi Nazarian, Kevin Lawlor, et al.
Nature Protocols
|
April 5, 2007
Data analysis of assorted serum peptidome profiles
Josep Villanueva, John Philip, Lin DeNoyer, et al.
Nature Protocols
|
April 5, 2007
Automated serum peptide profiling
Josep Villanueva, Kevin Lawlor, Ricardo Toledo-Crow, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 45) with videos related to
Sort By:
Page
of 5
Expert Review of Proteomics
|
December 15, 2010
PI3K-based molecular signatures link high PI3K pathway activity with low ER levels in ER+ breast cancer
Alex Sanchez, Josep Villanueva
Proteomics. Clinical Applications
|
November 25, 2014
Challenges and opportunities for cell line secretomes in cancer proteomics
Olga Méndez, Josep Villanueva
Nature
|
August 6, 2004
OvaCheck: let's not dismiss the concept
Josep Villanueva, Paul Tempst
Annals of Translational Medicine
|
August 15, 2020
Hitting the brakes on autophagy for overcoming acquired resistance in triple negative breast cancer
Chiara Bellio, Josep Villanueva
Methods in Molecular Biology (Clifton, N.J.)
|
October 29, 2022
msmsEDA & msmsTests: Label-Free Differential Expression by Spectral Counts
Josep Gregori, Àlex Sánchez, Josep Villanueva
Biomolecules
|
September 28, 2021
HMGA1, Moonlighting Protein Function, and Cellular Real Estate: Location, Location, Location!
Mireia Pujals, Linda Resar, Josep Villanueva
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 30, 2005
Distilling cancer biomarkers from the serum peptidome: high technology reading of tea leaves or an insight to clinical systems biology?
Richard J Robbins, Josep Villanueva, Paul Tempst
Nature Protocols
|
July 21, 2009
Monitoring peptidase activities in complex proteomes by MALDI-TOF mass spectrometry
Josep Villanueva, Arpi Nazarian, Kevin Lawlor, et al.
Nature Protocols
|
April 5, 2007
Data analysis of assorted serum peptidome profiles
Josep Villanueva, John Philip, Lin DeNoyer, et al.
Nature Protocols
|
April 5, 2007
Automated serum peptide profiling
Josep Villanueva, Kevin Lawlor, Ricardo Toledo-Crow, et al.
Page
of 5